These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29397578)

  • 1. Elevated mitochondrial activity distinguishes fibrogenic hepatic stellate cells and sensitizes for selective inhibition by mitotropic doxorubicin.
    Gajendiran P; Vega LI; Itoh K; Sesaki H; Vakili MR; Lavasanifar A; Hong K; Mezey E; Ganapathy-Kanniappan S
    J Cell Mol Med; 2018 Apr; 22(4):2210-2219. PubMed ID: 29397578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deregulation of energy metabolism promotes antifibrotic effects in human hepatic stellate cells and prevents liver fibrosis in a mouse model.
    Karthikeyan S; Potter JJ; Geschwind JF; Sur S; Hamilton JP; Vogelstein B; Kinzler KW; Mezey E; Ganapathy-Kanniappan S
    Biochem Biophys Res Commun; 2016 Jan; 469(3):463-9. PubMed ID: 26525850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells
    Li Z; Ding Q; Ling LP; Wu Y; Meng DX; Li X; Zhang CQ
    World J Gastroenterol; 2018 Feb; 24(7):819-832. PubMed ID: 29467552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria: A critical hub for hepatic stellate cells activation during chronic liver diseases.
    Ezhilarasan D
    Hepatobiliary Pancreat Dis Int; 2021 Aug; 20(4):315-322. PubMed ID: 33975780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibronectin Type III Domain-Containing 5 Attenuates Liver Fibrosis Via Inhibition of Hepatic Stellate Cell Activation.
    Zhou B; Ling L; Zhang F; Liu TY; Zhou H; Qi XH; Chen Q; Li YH; Kang YM; Zhu GQ
    Cell Physiol Biochem; 2018; 48(1):227-236. PubMed ID: 30007970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin protects against lipid-induced mitochondrial dysfunction in hepatocytes and inhibits stellate cell activation during hepatic fibrosis in mice.
    Das N; Mandala A; Naaz S; Giri S; Jain M; Bandyopadhyay D; Reiter RJ; Roy SS
    J Pineal Res; 2017 May; 62(4):. PubMed ID: 28247434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic stellate cells role in the course of metabolic disorders development - A molecular overview.
    Bourebaba N; Marycz K
    Pharmacol Res; 2021 Aug; 170():105739. PubMed ID: 34171492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C/EBP-α ameliorates CCl(4)-induced liver fibrosis in mice through promoting apoptosis of hepatic stellate cells with little apoptotic effect on hepatocytes in vitro and in vivo.
    Tao LL; Cheng YY; Ding D; Mei S; Xu JW; Yu J; Ou-Yang Q; Deng L; Chen Q; Li QQ; Xu ZD; Liu XP
    Apoptosis; 2012 May; 17(5):492-502. PubMed ID: 22307857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeic acid phenethyl ester attenuates pro-inflammatory and fibrogenic phenotypes of LPS-stimulated hepatic stellate cells through the inhibition of NF-κB signaling.
    Zhao WX; Wang L; Yang JL; Li LZ; Xu WM; Li T
    Int J Mol Med; 2014 Mar; 33(3):687-94. PubMed ID: 24378685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-cellular transitional organotypic models to investigate liver fibrosis.
    Orbach SM; Ford AJ; Saverot SE; Rajagopalan P
    Acta Biomater; 2018 Dec; 82():79-92. PubMed ID: 30316024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncostatin M causes liver fibrosis by regulating cooperation between hepatic stellate cells and macrophages in mice.
    Matsuda M; Tsurusaki S; Miyata N; Saijou E; Okochi H; Miyajima A; Tanaka M
    Hepatology; 2018 Jan; 67(1):296-312. PubMed ID: 28779552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fucoxanthin exerts anti-fibrogenic effects in hepatic stellate cells.
    Kim MB; Bae M; Hu S; Kang H; Park YK; Lee JY
    Biochem Biophys Res Commun; 2019 Jun; 513(3):657-662. PubMed ID: 30982574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats.
    Li J; Liu P; Zhang R; Cao L; Qian H; Liao J; Xu W; Wu M; Yin Z
    J Ethnopharmacol; 2011 Sep; 137(1):714-23. PubMed ID: 21726622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gallic acid selectively induces the necrosis of activated hepatic stellate cells via a calcium-dependent calpain I activation pathway.
    Hsieh SC; Wu CH; Wu CC; Yen JH; Liu MC; Hsueh CM; Hsu SL
    Life Sci; 2014 Apr; 102(1):55-64. PubMed ID: 24631138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of cromolyn sodium as an anti-fibrotic agent targeting both hepatocytes and hepatic stellate cells.
    Choi JS; Kim JK; Yang YJ; Kim Y; Kim P; Park SG; Cho EY; Lee DH; Choi JW
    Pharmacol Res; 2015 Dec; 102():176-83. PubMed ID: 26453959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the nuclear high mobility group B1 peptides released from injured hepatocytes in murine hepatic fibrogenesis.
    Kao YH; Lin YC; Tsai MS; Sun CK; Yuan SS; Chang CY; Jawan B; Lee PH
    Biochim Biophys Acta; 2014 Sep; 1842(9):1720-32. PubMed ID: 24970745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collagenase-I decorated co-delivery micelles potentiate extracellular matrix degradation and hepatic stellate cell targeting for liver fibrosis therapy.
    Zhou L; Liang Q; Li Y; Cao Y; Li J; Yang J; Liu J; Bi J; Liu Y
    Acta Biomater; 2022 Oct; 152():235-254. PubMed ID: 36087869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of distinct ECM microenvironments on the genome-wide chromatin accessibility and gene expression responses of hepatic stellate cells.
    Jain I; Brougham-Cook A; Underhill GH
    Acta Biomater; 2023 Sep; 167():278-292. PubMed ID: 37343907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of dimethyl α-ketoglutarate in hepatic stellate cell activation.
    Zhao J; Peng L; Luo Z; Cui R; Yan M
    Int J Clin Exp Pathol; 2015; 8(5):5471-7. PubMed ID: 26191252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-specific PPARγ deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells.
    Morán-Salvador E; Titos E; Rius B; González-Périz A; García-Alonso V; López-Vicario C; Miquel R; Barak Y; Arroyo V; Clària J
    J Hepatol; 2013 Nov; 59(5):1045-53. PubMed ID: 23831119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.